Cellevate
Business Services · Sweden · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Scheelevägen Medicon Village 8, Lund, Sk...Phone Number
+46 736333390Website
www.cellevate.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
1
1
1
1
1
About Cellevate
Cellevate AB is a biotech company specializing in next-generation cell culture products for upstream bioprocessing, utilizing their proprietary nanofiber technology, Cellevat3d. Their innovative products, including Cellevat3d VAX microcarriers, significantly enhance viral vaccine production yields and streamline the biomanufacturing process. The company targets biopharmaceutical firms and CDMOs, aiming to advance life-changing therapies while promoting sustainability through biodegradable materials. Cellevate is ISO 9001:2015 certified and committed to reducing production costs and environmental impact in the biopharmaceutical industry.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Cellevate your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Cellevate had a recent Job posting/layoffs
Check out if Cellevate is spiking on competitors!
Cellevate, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when Cellevate launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once Cellevate has new funding data
Check if Cellevate has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at Cellevate
Earning: See what the market has to say on Cellevate recently announced quarterly report
Recommended Actions
Reach out to Masked Content who joined Cellevate as Masked Content
Find 2 more new buyers
Company Profile Activity
Activity Insights
Cellevate is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Cellevate is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Cellevate.
Cellevate financials insights
Gather financial insights about Cellevate, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2024
Angel/Seed
$7.2M
Cellevate Tech Stack
A closer look at the technologies used by Cellevate
See more technologies
Cellevate News & Media
Cellevate appoints Christel Fenge chief technology officer - Specialty Fabrics Review
Cellevate AB announced the appointment of Christel Fenge, Ph.D., as chief technology officer (CTO) and member of the management team.Cellevate demonstrates successful scale-up of its Cellevat3d[®] nanofiber microcarriers at Testa Center
LUND, Sweden, October 25, 2024 - Cellevate, an innovative biotech company developing next-generation cell culture systems to revolutionize biomanufacturing, is excited to announce the successful scale-up of its ground-breaking Cellevat3d[®] nanofiber microcarriers funded by Vinnova/STUNS Life Science (https://cellevate.com/cellevate-awarded-vinnova-stuns-life-science-grant-to-run-cellevat3d-microcarriers-scale-up-validation-for-aav-production-at-testa-center/). The study was performed at Testa CCellevate to pre-launch first nanofiber microcarriers for boosting viral vector production in gene therapy applications at CPHI Milan
LUND, Sweden - Cellevate, an innovative biotech company developing next-generation cell culture systems to revolutionize biomanufacturing, is ready to pre-launch the world’s 1[st] nanofiber microcarrier for gene therapy at CPHI Milan, October 8-10, 2024. By providing up to 60 times more surface area for cell growth than conventional systems, Cellevat3d[®] nanofiber microcarriers increase yield and productivity in upstream bioprocessing of gene therapy applications. Engineered for stirred tank biCellevate closes second seed round, raising 3.2 MEUR to enter into global commercialization
LUND, Sweden, September 16, 2024 – Cellevate, an innovative biotech company developing next-generation cell culture systems to revolutionize biomanufacturing, announced today the successful closure of its recent second seed round led by Industrifonden in syndication with the European Innovation Council Fund (EIC Fund), securing a total of 3.2 MEUR. By achieving commercial and technical readiness in Q3 2024, Cellevate is preparing for the aggressive commercialization of the first product, Celleva
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Cellevate
Sign Up For FreeTo access detailed company insights
Cellevate AB is a biotech company specializing in next-generation cell culture products for upstream bioprocessing, utilizing their proprietary nanofiber technology, Cellevat3d. Their innovative products, including Cellevat3d VAX microcarriers, significantly enhance viral vaccine production yields and streamline the biomanufacturing process. The co... Read More
